Anti-TNF-associated palmoplantar pustulosis

Journal of Clinical Rheumatology

Volumn 16, Issue 3, 2010, Pages 138-139

  Pyrpasopoulou, Athina ^a   Chatzimichailidou, Sofia ^a   Simoulidou, Elisavet ^a   Aslanidis, Spyros ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; INFLIXIMAB;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MALE; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS;

ANTIBODIES, MONOCLONAL; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951072159     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181d59511     Document Type: Article

References (12)

1. Beuthien W, Mellinghoff HU, von Kempis J. Skin reaction to adalimumab. Arthritis Rheum. 2004;50:1690-1692.
2. Sobell JM, Kalb RE, Weinberg JM. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents. J Drugs Dermatol. 2009;8:147-154.
3. Roux CH, Brocq O, Leccia N, et al. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol. 2007; 34:434-437.
4. Bal A, Gurcay E, Aydog E, et al. Onset of psoriasis induced by infliximab. J Clin Rheumatol. 2008;14:128-129; author reply 130.
5. Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-alpha inhibitorinduced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9:1-14.
6. Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatol Treat. 2008;16:1-8.
7. Aslanidis S, Pyrpasopoulou A, Douma S, et al. Tumor necrosis factor-a antagonist- induced psoriasis: yet another paradox in medicine. Clin Rheumatol. 2008; 27:377-380.
8. Cuchacovich R, Espinoza CG, Virk Z, et al. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha? J Clin Rheumatol. 2008;14:353-356.
9. Cohen JD, Bournerias I, Buffard V, et al. Psoriasis induced by tumor necrosis factor-a antagonist therapy: a case series. J Rheumatol. 2007;34: 380-385.
10. Kary S, Worm M, Audring H, et al. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis. 2006;65:405-407.
11. Sfikakis PP, Iliopoulos A, Elezoglou A, et al. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005;52:2513-2518.
12. Bosch RI, Amo Ndel V, Manteca CF, et al. Psoriasis induced by anti TNF probably not so uncommon. J Clin Rheumatol. 2008;14:128; author reply 130.